We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.1B
AUM Growth
+$1.81B
Cap. Flow
+$2.06B
Cap. Flow %
5%
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$267M
2
DE icon
Deere & Co
DE
+$139M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M
4
JPM icon
JPMorgan Chase
JPM
+$114M
5
CVX icon
Chevron
CVX
+$88.5M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$90M
2
CMCSA icon
Comcast
CMCSA
+$36M
3
UNP icon
Union Pacific
UNP
+$19.2M
4
HES
Hess
HES
+$19.2M
5
KMPR icon
Kemper
KMPR
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 18.99%
3 Healthcare 11.19%
4 Consumer Staples 11.19%
5 Energy 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
251
CVS Health
CVS
$121B
$371K ﹤0.01%
8,273
-1,200
-13% -$67.3K
VABK icon
252
Virginia National Bankshares
VABK
$263M
$359K ﹤0.01%
9,402
-317
-3% -$13K
HALO icon
253
Halozyme
HALO
$12.1B
$359K ﹤0.01%
+7,500
New +$385K
ANET icon
254
Arista Networks
ANET
$243B
$355K ﹤0.01%
3,216
-200
-6% -$20.6K
URI icon
255
United Rentals
URI
$61.6B
$352K ﹤0.01%
500
– –
BIIB icon
256
Biogen
BIIB
$31.9B
$352K ﹤0.01%
2,300
– –
TT icon
257
Trane Technologies
TT
$93B
$352K ﹤0.01%
+952
New +$378K
CG icon
258
Carlyle Group
CG
$14.8B
$346K ﹤0.01%
6,849
– –
IJR icon
259
iShares Core S&P Small-Cap ETF
IJR
$106B
$345K ﹤0.01%
2,996
– –
XYL icon
260
Xylem
XYL
$25.1B
$344K ﹤0.01%
+2,964
New +$375K
MU icon
261
Micron Technology
MU
$1.05T
$343K ﹤0.01%
4,078
– –
VTOL icon
262
Bristow Group
VTOL
$1.25B
$343K ﹤0.01%
+10,000
New +$353K
CRWD icon
263
CrowdStrike
CRWD
$248B
$342K ﹤0.01%
4,000
– –
NMFC icon
264
New Mountain Finance
NMFC
$682M
$341K ﹤0.01%
30,272
– –
NOMD icon
265
Nomad Foods
NOMD
$1.53B
$336K ﹤0.01%
+20,000
New +$349K
BMY icon
266
Bristol-Myers Squibb
BMY
$130B
$334K ﹤0.01%
5,898
– –
DOW icon
267
Dow Inc
DOW
$21.6B
$332K ﹤0.01%
8,280
– –
HLT icon
268
Hilton Worldwide
HLT
$69.3B
$330K ﹤0.01%
1,336
– –
KLG
269
DELISTED
WK Kellogg Co
KLG
$324K ﹤0.01%
17,993
-665
-4% -$12.2K
OGN icon
270
Organon & Co
OGN
$3.59B
$322K ﹤0.01%
21,595
-8,204
-28% -$134K
POWL icon
271
Powell Industries
POWL
$6.24B
$321K ﹤0.01%
+4,350
New +$389K
IWM icon
272
iShares Russell 2000 ETF
IWM
$76.9B
$310K ﹤0.01%
1,404
+1
+0.1% +$228
KLAC icon
273
KLA
KLAC
$220B
$310K ﹤0.01%
4,920
-1,750
-26% -$118K
MRSH
274
Marsh
MRSH
$85.8B
$308K ﹤0.01%
1,450
– –
AEP icon
275
American Electric Power
AEP
$65.7B
$300K ﹤0.01%
3,250
-300
-8% -$29K
9 10
11
12 13

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fayez Sarofim & Co held 315 positions worth $41.1B, up 4.6% from $39.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co deployed $2.06B of net new capital in Q4 2024, opening 30 new positions and adding to 123 existing holdings. Its largest new stake was Copart: 158,575 shares worth $9.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $90M trimmed.

  • Fayez Sarofim & Co's largest Q4 2024 buy was Copart: 158,575 shares worth $9.1M.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2024, an estimated $267M increase.
  • Fayez Sarofim & Co's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $90M.
  • Fayez Sarofim & Co fully exited Bruker in Q4 2024, selling an estimated $227K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.1B portfolio in Q4 2024.
  • Fayez Sarofim & Co opened 30 new positions and closed 3 in Q4 2024.
  • Fayez Sarofim & Co's portfolio value rose 4.6% quarter-over-quarter to $41.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.